Reiter A, Zimmermann W, Zimmermann M, von Schweinitz D, Riehm H, Mildenberger H
Department of Pediatric Hematology and Oncology, Medizinische Hochschule Hannover, Germany.
Eur J Pediatr Surg. 1994 Apr;4(2):74-81. doi: 10.1055/s-2008-1066072.
The aim of this study was to determine the role of surgery in the treatment of abdominal B-cell non-Hodgkin's lymphomas (B-NHL) in children. We analyzed the effect of surgical variables of initial laparotomy and second-look surgery on event-free survival (EFS) of 177 patients with abdominal B-NHL enrolled into the three consecutive multicenter trials NHL-BFM 81, NHL-BFM 83, and NHL-BFM 86. The therapy regimen was comparable in all 3 trials as well as the overall outcome of the patients. Patients with stage II and complete resection received 3 courses of therapy (4 in trial NHL-BFM 81), patients with stage II not resected, stage III, and stage IV received 6 courses of therapy (8 in trial NHL-BFM 81). An initial laparotomy was performed in 161 patients, in 59 of them as an urgent procedure. Complete resection of the abdominal primary was performed in 43 patients, 40 of them had a localized bowel tumor. The probability of EFS (pEFS) at 5 years is 95%, 69%, 62%, and 67% for patients with complete resection, subtotal resection (n = 36), partial resection (n = 21), or biopsy only (n = 61), respectively. Complete resection was achieved in 30 out of 40 patients with stage II, but only in 12 of 113 and 1 of 24 patients with stage III and IV, respectively. pEFS at 5 years according to stage and completeness of resection is as follows: stage II complete resected 97%; stage II not complete resected 100%; stage III/IV complete resected 92%; stage III/IV not complete resected 63%.(ABSTRACT TRUNCATED AT 250 WORDS)
本研究的目的是确定手术在儿童腹部B细胞非霍奇金淋巴瘤(B-NHL)治疗中的作用。我们分析了初次剖腹手术和二次探查手术的手术变量对177例纳入连续三项多中心试验NHL-BFM 81、NHL-BFM 83和NHL-BFM 86的腹部B-NHL患者无事件生存期(EFS)的影响。所有3项试验中的治疗方案以及患者的总体结局具有可比性。II期且完全切除的患者接受3个疗程的治疗(在试验NHL-BFM 81中为4个疗程),II期未切除、III期和IV期的患者接受6个疗程的治疗(在试验NHL-BFM 81中为8个疗程)。161例患者进行了初次剖腹手术,其中59例为急诊手术。43例患者完成了腹部原发灶的完全切除,其中40例有局限性肠肿瘤。完全切除、次全切除(n = 36)、部分切除(n = 21)或仅活检(n = 61)的患者5年无事件生存概率(pEFS)分别为95%、69%、62%和67%。40例II期患者中有30例实现了完全切除,但III期和IV期的113例患者中分别只有12例和24例中的1例实现了完全切除。根据分期和切除完整性的5年pEFS如下:II期完全切除97%;II期未完全切除100%;III/IV期完全切除92%;III/IV期未完全切除63%。(摘要截断于250字)